Inventor
CAMERON BEATRICE
FR36 patents
⚠️ This page may combine multiple inventors who share the name “CAMERON BEATRICE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA SA
8 patentsUS6410273B1Jun 25, 2002
Method for producing methylated DNA
AVENTIS PHARMA SA28 citations92
US6319672B1Nov 20, 2001
Purification of a triple helix formation with an immobilized oligonucleotide
AVENTIS PHARMA SA16 citations92
US6492164B1Dec 10, 2002
Circular DNA expression cassettes for gene transfer
AVENTIS PHARMA SA17 citations91
US6207150B1Mar 27, 2001
Variants of thymidine kinase, nucleic acids encoding them, and methods of using them
AVENTIS PHARMA SA32 citations91
US6537793B2Mar 25, 2003
Method of separating viral particles
AVENTIS PHARMA SA44 citations89
US6518062B1Feb 11, 2003
Enzyme combinations for destroying proliferative cells
AVENTIS PHARMA SA9 citations72
US6153597ANov 28, 2000
Pharmaceutical composition useful for nucleic acid transfection, and use thereof
AVENTIS PHARMA SA13 citations72
US6649394B1Nov 18, 2003
Topoisomerase IV, corresponding nucleotide sequences and uses thereof
AVENTIS PHARMA SA0 citations49
SANOFI SA
8 patentsUS10112991B2Oct 30, 2018
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
SANOFI SA2 citations71
US9382312B2Jul 5, 2016
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
SANOFI SA2 citations61
US8980262B2Mar 17, 2015
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
SANOFI SA1 citations59
US9441040B2Sep 13, 2016
Antagonist antibodies and their fab fragments against GPVI and uses thereof
SANOFI SA0 citations50
US9815902B2Nov 14, 2017
Humanized anti-CXCR5 antibodies, derivatives thereof and their uses
SANOFI SA0 citations49
US9243067B2Jan 26, 2016
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
SANOFI SA0 citations49
US9228019B2Jan 5, 2016
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
SANOFI SA0 citations49
US9175087B2Nov 3, 2015
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
SANOFI SA0 citations49
RHONE POULENC RORER SA
4 patentsUS6143530ANov 7, 2000
Circular DNA expression cassettes for in vivo gene transfer
RHONE POULENC RORER SA71 citations94
US6001631ADec 14, 1999
Topoisomerase IV, corresponding nucleotide sequences and uses thereof
RHONE POULENC RORER SA7 citations70
US6143518ANov 7, 2000
Method for the production of recombinant proteins, plasmids and modified cells
RHONE POULENC RORER SA8 citations66
US6156545ADec 5, 2000
Biosynthesis method enabling the preparation of cobalamins
RHONE POULENC RORER SA3 citations61
CENTELION
4 patentsUS7038026B2May 2, 2006
Purification of a triple heli formation with an immobilized oligonucleotide
CENTELION10 citations73
US8017744B2Sep 13, 2011
Purification of a triple helix formation with an immobilized oligonucleotide
CENTELION1 citations62
US7514218B2Apr 7, 2009
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
CENTELION0 citations52
US7052838B2May 30, 2006
Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction
CENTELION0 citations52
RHONE POULENC BIOCHIMIE
4 patentsUS5691163ANov 25, 1997
Cells with altered betaine catabolism and their use in producing metabolites or enzymes
RHONE POULENC BIOCHIMIE10 citations73
US5670343ASep 23, 1997
Cloning and/or expression vectors, preparation method and their use
RHONE POULENC BIOCHIMIE7 citations71
US6656709B1Dec 2, 2003
Methods of increasing the production of cobalamins using cob gene expression
RHONE POULENC BIOCHIMIE4 citations60
USRE38331ENov 25, 2003
Cells with altered betaine catabolism and their use in producing metabolites or enzymes
RHONE POULENC BIOCHIMIE0 citations51
BLANCHE FRANCIS
3 patentsUS9493529B2Nov 15, 2016
Robo1-Fc fusion protein and use thereof for treating tumours
BLANCHE FRANCIS20 citations87
US8119770B2Feb 21, 2012
Modified soluble FGF receptor Fc fusions with improved biological activity
BLANCHE FRANCIS19 citations86
US8481487B2Jul 9, 2013
Modified soluble FGF receptor Fc fusions method
BLANCHE FRANCIS0 citations46